Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Reports Severe Drop in Q3 Revenue, Widened Net Loss

NEW YORK, Oct. 24 - Luminex today reported a significant drop in third-quarter revenues, fallen R&D spending, and widened net loss.

 

For the three-month period ended Sept. 30, total revenue came to $3.6 million compared with $6.2 million in the same quarter one year ago, a decrease that acting CFO Harris Currie blamed on "slower than anticipated commercialization" of the firm's products.

 

R&D spending in the quarter fell to $1.2 million from $1.9 million, said the company, which reported it burned $1.5 million in the quarter. Consequently, net loss in the third quarter swelled to $5.5 million, or $.19 per share, from $3.6 million, or $.13 per share, year over year, the Luminex said.

 

The company said it had approximately $40.3 million in cash and short-term investments as of Sept. 30.

 

Click here for more information.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.